Details of the Drug
General Information of Drug (ID: DM4YQR2)
Drug Name |
xestospongin C
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
xestospongin c; 88903-69-9; Xestospongin; (-)-xestospongin C; C28H50N2O2; KBioGR_000612; BSPBio_001272; KBioSS_000612; SCHEMBL5163114; GTPL4344; KBio2_003180; KBio2_005748; KBio3_001084; KBio3_001083; KBio2_000612; HMS1990P13; Bio2_000476; HMS1792P13; CA409; Bio2_000956; HMS1362P13; XeC; ZINC33822036; 2102AH; MFCD01862629; IDI1_002231; NCGC00163490-02; C-22436
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL is unavailable | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 446.7 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 7.4 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References